Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/1999
03/24/1999CN1042633C Alkoxy alkyl carbamates from imidazo (1,2-a) pyridines
03/24/1999CN1042632C Pyridone carboxylic acid derivatives, intermediate and pharmaceutical composition for preparing same
03/23/1999US5886191 Anticoagulants
03/23/1999US5886183 Mass dyeing of high molecular weight organic material, laser dyes of printing toners, colour filters, organic photoreceptors, electroluminescent and photoluminescent elements, optical information storage media or solar cells
03/23/1999US5886177 Phosphate linked oligomers
03/23/1999US5886175 Tetracycline antibiotics
03/23/1999US5886043 Antiarthritic agents, antitumor agents, antiinflammatory agents
03/23/1999US5886024 Thiophene-containing butonic acid derivatives as matrix metalloprotease inhibitors
03/23/1999US5886008 5-arylindole derivatives
03/23/1999US5886006 Fused cycloalkylimidazopyridines
03/23/1999US5886004 Tetrahydrobetacarboline compounds
03/23/1999US5886003 Administering 5-ht2 antagonists
03/23/1999US5885997 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
03/18/1999WO1999012926A1 Tetrahydro gamma-carbolines
03/18/1999WO1999012911A1 Method for producing (hetero)aromatic hydroxylamines
03/18/1999WO1999012908A1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity
03/18/1999WO1999012877A1 Enantioselective reduction of ketones with a silane agent/metal compound/chiral ligand system
03/18/1999DE19740110A1 New hydroxy substituted benzomorphan derivatives
03/18/1999CA2301807A1 Tetrahydro gamma-carbolines
03/18/1999CA2298533A1 Reduction enantioselective de cetones avec un systeme agent silanique/compose metallique/ligand chiral
03/17/1999EP0902029A1 Pyrimidinone derivatives and herbicides containing them
03/17/1999EP0901482A1 Benzofuran carboxamides and their therapeutic use
03/17/1999EP0901476A1 Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives
03/17/1999EP0901471A1 Antagonists of gonadotropin releasing hormone
03/17/1999EP0901374A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
03/17/1999EP0789699B1 SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
03/17/1999EP0626962B1 Substituted phenylheterocyclic herbicides
03/17/1999CN1210861A Pyrimidinone derivatives and herbicides containing them
03/17/1999CN1210859A New benzimidazole, benzoxazole and benzothiazole compounds, process for their preparation and pharmaceutical compositions containing them
03/16/1999US5883255 Substituted indolizino 1,2-b!quinolinones
03/16/1999US5883111 Heterocyclic compounds and their use as angiotensin antagonists
03/16/1999US5883102 Pharmaceutically active compounds
03/16/1999US5883049 Hydantoin derivatives and herbicides containing said derivatives as active ingredient
03/16/1999CA2158108C Compositions containing sertraline and a 5-ht1d receptor agonist or antagonist
03/16/1999CA2081891C Quinolizinone type compounds
03/16/1999CA2058264C Dihydrobenzofuran carboxamides and process for their preparation
03/11/1999WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999WO1999011644A1 Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
03/11/1999WO1999011643A1 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
03/11/1999WO1999011642A1 Aminometyl oxooxazolidinyl benzene derivatives
03/11/1999WO1999011631A1 Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
03/11/1999WO1999011628A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/11/1999WO1999011624A1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
03/11/1999WO1999011623A1 Thioalkyl compounds, methods, and compositions for inhibiting parp activity
03/11/1999WO1999011622A1 Amino-substituted compounds, methods, and compositions for inhibiting parp activity
03/11/1999WO1999011619A1 Phenylindole derivatives as 5-ht2a receptor ligands
03/11/1999DE19738862A1 Production of aromatic or heterocyclic hydroxylamine derivatives
03/11/1999CA2303280A1 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
03/11/1999CA2299367A1 Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
03/11/1999CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999CA2294118A1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
03/11/1999CA2294110A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/10/1999EP0900799A1 Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/10/1999EP0900796A1 Preventives and remedies for ischemic intestinal lesion and ileus
03/10/1999EP0900220A1 3- and 3,8-substituted 1,10-phenanthrolines and their use in electron and energy transfer processes
03/10/1999EP0900218A1 Heterocyclic compounds
03/10/1999EP0900086A1 Enhancement of sleep with a growth hormone secretagogue
03/10/1999EP0649425B1 Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents
03/10/1999CN1210531A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/10/1999CN1210521A Isoquinoline derivatives and drugs
03/09/1999US5880136 Sulfonamide fibrinogen receptor antagonists
03/09/1999US5880126 9H-Pyridu ((3,4-b) indole derivatives
03/09/1999US5880125 4-spiroindoline piperidines promote release of growth hormone
03/04/1999WO1999010349A1 Oxindolylquinazoline derivatives as angiogenesis inhibitors
03/04/1999WO1999010347A1 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
03/04/1999WO1999010342A1 Antibiotic oxazolidinone derivatives
03/04/1999WO1999010339A1 2-aminopyridines containing fused ring substituents as nos inhibitors
03/04/1999WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
03/04/1999WO1999010312A1 N-alkanoylphenylalanine derivatives
03/04/1999WO1999009996A1 Camptothecin analogs and methods of preparation thereof
03/04/1999WO1999009990A1 Pharmaceutical suspension comprising nevirapine hemihydrate
03/03/1999EP0898571A1 Thieno-pyridine sulfonamides, derivatives thereof and related compounds that modulate the activity of endothelin
03/03/1999EP0745080B1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
03/03/1999EP0737194B1 Diazabicyclic neurokinin antagonists
03/03/1999EP0724570B1 Amidino derivatives useful as nitric oxide synthase inhibitors
03/03/1999EP0705260B1 Condensed 4-aminopyridines with antirheumatic activity
03/03/1999EP0674641B1 Pyrrolopyrimidines as crf antagonists
03/03/1999CN1209803A Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method therefor
03/03/1999CN1209744A Vitronectin receptor antagonists
03/02/1999US5877199 Heterocyclic compounds, their preparation and their therapeutic use
03/02/1999US5877182 Piperidines promote release of growth hormone
03/02/1999US5877178 Aids therapy
02/1999
02/25/1999WO1999009200A1 Method for racemic biochemical resolution of cis- and trans- pyrrolopiperidine
02/25/1999WO1999009030A1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
02/25/1999WO1999009029A1 PYRROLO[3,2-c]QUINOLINE DERIVATIVES CONTAINING HALOALKOXY GROUP AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
02/25/1999WO1999009028A1 Crystalline polymorphic forms of 3-{2-[4-6-fluorobenzo[d] isoxazol-3-yl) -3,6-dihydro-2h-pyridine-1-yl] -ethyl]-2-methyl-6,7, 8,9-tetrahydropyrido [1,2-a]pyrimidine-4-one and process for producing the forms
02/25/1999CA2300119A1 Method for racemic biochemical resolution of cis- and trans- pyrrolopiperidine
02/24/1999EP0897924A1 Process for the preparation of tetrahydro-indolizines
02/24/1999EP0897912A1 Amidino derivatives useful as nitric oxide synthase inhibitors
02/24/1999EP0897387A1 New benzazepine derivatives, medicaments containing the same and their use to prepare medicaments
02/24/1999CN1209131A 1,7-diaroxy-or 1,7-diarylthio-substituted perylene-3,4,9,10-tetracarboxylic acid and their dianhydrides and diimides
02/24/1999CN1209129A Antagonists of gonadotropin releasing hormone
02/24/1999CN1042228C Antiallergic imidazoazepines
02/24/1999CN1042227C Bicyclic amidine prepn. method
02/24/1999CN1042226C Heterocyclic derivatives and method for preparing the salt thereof
02/23/1999US5874587 Imidazolium cations, processes for their preparation, and uses therefor
02/23/1999US5874473 Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors
02/23/1999US5874441 Carbocyclic and hetertocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
02/23/1999US5874437 Impotence
02/23/1999US5874435 Psychological disorders; analgesics
1 ... 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 ... 646